JPWO2020209350A1 - - Google Patents

Info

Publication number
JPWO2020209350A1
JPWO2020209350A1 JP2021513709A JP2021513709A JPWO2020209350A1 JP WO2020209350 A1 JPWO2020209350 A1 JP WO2020209350A1 JP 2021513709 A JP2021513709 A JP 2021513709A JP 2021513709 A JP2021513709 A JP 2021513709A JP WO2020209350 A1 JPWO2020209350 A1 JP WO2020209350A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021513709A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020209350A1 publication Critical patent/JPWO2020209350A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
JP2021513709A 2019-04-12 2020-04-10 Pending JPWO2020209350A1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019076376 2019-04-12
PCT/JP2020/016062 WO2020209350A1 (ja) 2019-04-12 2020-04-10 糖尿病治療用口腔内速崩壊錠

Publications (1)

Publication Number Publication Date
JPWO2020209350A1 true JPWO2020209350A1 (pt) 2020-10-15

Family

ID=72751341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021513709A Pending JPWO2020209350A1 (pt) 2019-04-12 2020-04-10

Country Status (2)

Country Link
JP (1) JPWO2020209350A1 (pt)
WO (1) WO2020209350A1 (pt)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04257525A (ja) * 1991-02-08 1992-09-11 Shin Etsu Chem Co Ltd 易崩壊性パンクレアチン顆粒剤
KR20120046766A (ko) * 2009-08-11 2012-05-10 다이닛본 스미토모 세이야꾸 가부시끼가이샤 2종 이상의 입자들을 함유하는 구강 속붕해성 정제
JP5775463B2 (ja) * 2009-12-18 2015-09-09 田辺三菱製薬株式会社 溶出安定性製剤
CN104644580A (zh) * 2013-11-25 2015-05-27 天津市汉康医药生物技术有限公司 一种替格列汀的药物组合物
WO2015132679A1 (en) * 2014-03-05 2015-09-11 Glenmark Pharmaceuticals Ltd Teneligliptin compositions
WO2016104643A1 (ja) * 2014-12-25 2016-06-30 田辺三菱製薬株式会社 糖尿病治療用固形製剤
EP3359156B1 (en) * 2015-10-07 2022-07-20 Steerlife India Private Limited Rapidly disintegrating tablet compositions of dpp-iv inhibitors with low mineral content
CN108884089A (zh) * 2017-02-03 2018-11-23 格伦马克制药有限公司 特力利汀盐的草酸盐及其溶剂合物、中间体、制备方法及其标记物

Also Published As

Publication number Publication date
WO2020209350A1 (ja) 2020-10-15

Similar Documents

Publication Publication Date Title
BR112019017762A2 (pt)
BR112021017339A2 (pt)
BR112021013854A2 (pt)
BR112021018450A2 (pt)
BR112021017892A2 (pt)
BR112019016141A2 (pt)
AU2020104490A4 (pt)
BR112021017939A2 (pt)
BR112021017738A2 (pt)
BR112021017782A2 (pt)
BR112019016138A2 (pt)
BR112019016142A2 (pt)
BR112021018168A2 (pt)
BR112021017355A2 (pt)
BR112021018102A2 (pt)
BR112021018452A2 (pt)
BR112021012348A2 (pt)
BR112021018250A2 (pt)
BR112021018093A2 (pt)
BR112021018084A2 (pt)
BR112021013944A2 (pt)
BR112021013128A2 (pt)
BR112021018484A2 (pt)
BR112021017732A2 (pt)
BR112021017949A2 (pt)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231205

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240327